ristocetin and Plasmacytoma

ristocetin has been researched along with Plasmacytoma* in 1 studies

Other Studies

1 other study(ies) available for ristocetin and Plasmacytoma

ArticleYear
Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
    Proceedings of the National Academy of Sciences of the United States of America, 1982, Volume: 79, Issue:1

    A series of monoclonal antibodies have been raised against a preparation of the factor VIII/von Willebrand factor molecule. Of the seven hybridomas showing specific activity against the factor VIII molecule in a solid-phase radioimmunoassay, three (F4.55, F4.77, and F4.264) have been shown to partially inhibit ristocetin-induced platelet aggregation and two (F4.115 and F4.415) inhibit the antihemophilic activity of the factor VIII molecule. An additional monoclonal antibody was directed against a contaminant of the factor VIII preparation and is an antifibrinogen antibody.

    Topics: Animals; Antibodies, Monoclonal; Cell Line; Factor VIII; Humans; Hybridomas; Mice; Mice, Inbred Strains; Plasmacytoma; Radioimmunoassay; Ristocetin; Spleen; von Willebrand Factor

1982